Kristian Valind Selected Research

1,3-ditolylguanidine

1/2012

Effects of the sigma-1 receptor agonist 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)-piperazine dihydro-chloride on inflammation after stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristian Valind Research Topics

Disease

1	Hypoxia (Hypoxemia) 01/2012
1	Infarction (Infarctions) 01/2012
1	Inflammation (Inflammations) 01/2012
1	Stroke (Strokes) 01/2012

Drug/Important Bio-Agent (IBA)

1	1,3-ditolylguanidineIBA 01/2012
1	SA 4503IBA 01/2012
1	Sigma-1 ReceptorIBA 01/2012
1	CalciumIBA 01/2012
1	ChloridesIBA 01/2012
1	Interferon-gamma (Interferon, gamma)IBA 01/2012
1	LigandsIBA 01/2012
1	NitritesIBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012
1	Interleukin-4 (Interleukin 4)IBA 01/2012
1	Interleukin-5 (Interleukin 5)IBA 01/2012
1	CytokinesIBA 01/2012
1	sigma Receptors (sigma Receptor)IBA 01/2012
1	Interleukin-13IBA 01/2012
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2012
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2012